{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:41:20Z","timestamp":1793108480701,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82025003"],"award-info":[{"award-number":["82025003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230092"],"award-info":[{"award-number":["82230092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41375-026-03102-1","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:31:42Z","timestamp":1787308302000},"page":"2503-2515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogenic DHX15 mutation enhances mitochondrial metabolism and sustains leukemia stemness"],"prefix":"10.1038","volume":"40","author":[{"given":"Qilong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-1036","authenticated-orcid":false,"given":"Peiqi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinpeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7892-2860","authenticated-orcid":false,"given":"Guoliang","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8360-6395","authenticated-orcid":false,"given":"Huafeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4821-5946","authenticated-orcid":false,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3798-9583","authenticated-orcid":false,"given":"Zhaoqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-6048","authenticated-orcid":false,"given":"Hudan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"3102_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.stem.2021.02.013","volume":"28","author":"CL Jones","year":"2021","unstructured":"Jones CL, Inguva A, Jordan CT. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell. 2021;28:378\u201393.","journal-title":"Cell Stem Cell"},{"key":"3102_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u20137.","journal-title":"Nat Med"},{"key":"3102_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica. 2023;108:353\u201366.","journal-title":"Haematologica"},{"key":"3102_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush LI, Mitchell A, Heisler L, Abelson S, Ng SWK, Trotman-Grant A, et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature. 2017;547:104\u20138.","journal-title":"Nature"},{"key":"3102_CR5","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/blood-2016-10-696054","volume":"129","author":"D Thomas","year":"2017","unstructured":"Thomas D, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017;129:1577\u201385.","journal-title":"Blood"},{"key":"3102_CR6","doi-asserted-by":"publisher","first-page":"e00206","DOI":"10.1097\/BS9.0000000000000206","volume":"6","author":"S Yao","year":"2024","unstructured":"Yao S, Guo R, Tian W, Zheng Y, Hu J, Han G, et al. Epigenetic modifications in hematopoietic ecosystem: a key tuner from homeostasis to acute myeloid leukemia. Blood Sci. 2024;6:e00206.","journal-title":"Blood Sci"},{"key":"3102_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12:329\u201341.","journal-title":"Cell Stem Cell"},{"key":"3102_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones CL, Stevens BM, D\u2019Alessandro A, Reisz JA, Culp-Hill R, Nemkov T, et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell. 2018;34:724\u201340.","journal-title":"Cancer Cell"},{"key":"3102_CR9","doi-asserted-by":"publisher","first-page":"e00271","DOI":"10.1097\/BS9.0000000000000271","volume":"8","author":"S Yi","year":"2026","unstructured":"Yi S, Zhang H, Sheng Y. Functions of mitochondrial metabolism in hematopoiesis and hematopoietic malignancies. Blood Sci. 2026;8:e00271.","journal-title":"Blood Sci"},{"key":"3102_CR10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz EM, Baquero P, Michie AM, Dunn K, Tardito S, Holyoake TL, et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat Med. 2017;23:1234\u201340.","journal-title":"Nat Med"},{"key":"3102_CR11","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018;24:1036\u201346.","journal-title":"Nat Med"},{"key":"3102_CR12","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","volume":"23","author":"LF Peterson","year":"2004","unstructured":"Peterson LF, Zhang DE. The 8;21 translocation in leukemogenesis. Oncogene. 2004;23:4255\u201362.","journal-title":"Oncogene"},{"key":"3102_CR13","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1182\/blood-2014-01-549212","volume":"124","author":"MA Hospital","year":"2014","unstructured":"Hospital MA, Prebet T, Bertoli S, Thomas X, Tavernier E, Braun T, et al. Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup. Blood. 2014;124:1312\u20139.","journal-title":"Blood"},{"key":"3102_CR14","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"3102_CR15","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1002\/j.1460-2075.1993.tb05933.x","volume":"12","author":"H Miyoshi","year":"1993","unstructured":"Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 1993;12:2715\u201321.","journal-title":"EMBO J"},{"key":"3102_CR16","doi-asserted-by":"publisher","first-page":"7185","DOI":"10.1128\/MCB.18.12.7185","volume":"18","author":"V Gelmetti","year":"1998","unstructured":"Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol. 1998;18:7185\u201391.","journal-title":"Mol Cell Biol"},{"key":"3102_CR17","doi-asserted-by":"publisher","first-page":"10860","DOI":"10.1073\/pnas.95.18.10860","volume":"95","author":"J Wang","year":"1998","unstructured":"Wang J, Hoshino T, Redner RL, Kajigaya S, Liu JM. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR\/mSin3\/HDAC1 complex. Proc Natl Acad Sci USA. 1998;95:10860\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3102_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1126\/science.1201662","volume":"333","author":"L Wang","year":"2011","unstructured":"Wang L, Gural A, Sun XJ, Zhao X, Perna F, Huang G, et al. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science. 2011;333:765\u20139.","journal-title":"Science"},{"key":"3102_CR19","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1182\/blood-2011-04-347476","volume":"119","author":"WJ Shia","year":"2012","unstructured":"Shia WJ, Okumura AJ, Yan M, Sarkeshik A, Lo MC, Matsuura S, et al. PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential. Blood. 2012;119:4953\u201362.","journal-title":"Blood"},{"key":"3102_CR20","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1182\/blood.V96.6.2108","volume":"96","author":"KL Rhoades","year":"2000","unstructured":"Rhoades KL, Hetherington CJ, Harakawa N, Yergeau DA, Zhou L, Liu LQ, et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood. 2000;96:2108\u201315.","journal-title":"Blood"},{"key":"3102_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29336-y","volume":"13","author":"T Liu","year":"2022","unstructured":"Liu T, Rao J, Hu W, Cui B, Cai J, Liu Y, et al. Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification. Nat Commun. 2022;13:1640.","journal-title":"Nat Commun"},{"key":"3102_CR22","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/ng.3709","volume":"48","author":"ZJ Faber","year":"2016","unstructured":"Faber ZJ, Chen X, Gedman AL, Boggs K, Cheng J, Ma J, et al. The genomic landscape of core-binding factor acute myeloid leukemias. Nat Genet. 2016;48:1551\u20136.","journal-title":"Nat Genet"},{"key":"3102_CR23","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.1093\/nar\/gkac687","volume":"50","author":"KE Bohnsack","year":"2022","unstructured":"Bohnsack KE, Kanwal N, Bohnsack MT. Prp43\/DHX15 exemplify RNA helicase multifunctionality in the gene expression network. Nucleic Acids Res. 2022;50:9012\u201322.","journal-title":"Nucleic Acids Res"},{"key":"3102_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cell.2017.08.029","volume":"171","author":"R Wan","year":"2017","unstructured":"Wan R, Yan C, Bai R, Lei J, Shi Y. Structure of an intron lariat spliceosome from saccharomyces cerevisiae. Cell. 2017;171:120\u201332.","journal-title":"Cell"},{"key":"3102_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216712119","volume":"119","author":"J Zhang","year":"2022","unstructured":"Zhang J, Huang J, Xu K, Xing P, Huang Y, Liu Z, et al. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer. Proc Natl Acad Sci USA. 2022;119:e2216712119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3102_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.molcel.2009.09.039","volume":"36","author":"MT Bohnsack","year":"2009","unstructured":"Bohnsack MT, Martin R, Granneman S, Ruprecht M, Schleiff E, Tollervey D. Prp43 bound at different sites on the pre-rRNA performs distinct functions in ribosome synthesis. Mol Cell. 2009;36:583\u201392.","journal-title":"Mol Cell"},{"key":"3102_CR27","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3324\/haematol.2022.282066","volume":"108","author":"H Guo","year":"2023","unstructured":"Guo H, Xu J, Xing P, Li Q, Wang D, Tang C, et al. RNA helicase DHX15 exemplifies a unique dependency in acute leukemia. Haematologica. 2023;108:2029\u201343.","journal-title":"Haematologica"},{"key":"3102_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108571","volume":"27","author":"Q Li","year":"2024","unstructured":"Li Q, Guo H, Xu J, Li X, Wang D, Guo Y, et al. A helicase-independent role of DHX15 promotes MYC stability and acute leukemia cell survival. iScience. 2024;27:108571.","journal-title":"iScience"},{"key":"3102_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.humpath.2018.10.006","volume":"84","author":"C Xie","year":"2019","unstructured":"Xie C, Liao H, Zhang C, Zhang S. Overexpression and clinical relevance of the RNA helicase DHX15 in hepatocellular carcinoma. Hum Pathol. 2019;84:213\u201320.","journal-title":"Hum Pathol"},{"key":"3102_CR30","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1349-7006.2009.01185.x","volume":"100","author":"ML Lin","year":"2009","unstructured":"Lin ML, Fukukawa C, Park JH, Naito K, Kijima K, Shimo A, et al. Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis. Cancer Sci. 2009;100:1443\u201350.","journal-title":"Cancer Sci"},{"key":"3102_CR31","doi-asserted-by":"publisher","first-page":"89643","DOI":"10.18632\/oncotarget.20288","volume":"8","author":"L Pan","year":"2017","unstructured":"Pan L, Li Y, Zhang HY, Zheng Y, Liu XL, Hu Z, et al. DHX15 is associated with poor prognosis in acute myeloid leukemia (AML) and regulates cell apoptosis via the NF-kB signaling pathway. Oncotarget. 2017;8:89643\u201354.","journal-title":"Oncotarget"},{"key":"3102_CR32","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41375-019-0697-0","volume":"34","author":"S Opatz","year":"2020","unstructured":"Opatz S, Bamopoulos SA, Metzeler KH, Herold T, Ksienzyk B, Br\u00e4undl K, et al. The clinical mutatome of core binding factor leukemia. Leukemia. 2020;34:1553\u201362.","journal-title":"Leukemia"},{"key":"3102_CR33","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1158\/0008-5472.CAN-15-1015","volume":"76","author":"JE Farrar","year":"2016","unstructured":"Farrar JE, Schuback HL, Ries RE, Wai D, Hampton OA, Trevino LR, et al. Genomic profiling of pediatric acute myeloid leukemia reveals a changing mutational landscape from disease diagnosis to relapse. Cancer Res. 2016;76:2197\u2013205.","journal-title":"Cancer Res"},{"key":"3102_CR34","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.stem.2024.09.008","volume":"31","author":"G Han","year":"2024","unstructured":"Han G, Cui M, Lu P, Zhang T, Yin R, Hu J, et al. Selective translation of nuclear mitochondrial respiratory proteins reprograms succinate metabolism in AML development and chemoresistance. Cell Stem Cell. 2024;31:1777\u201393.","journal-title":"Cell Stem Cell"},{"key":"3102_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41422-022-00735-6","volume":"32","author":"CL Hu","year":"2022","unstructured":"Hu CL, Chen BY, Li Z, Yang T, Xu CH, Yang R, et al. Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia. Cell Res. 2022;32:1105\u201323.","journal-title":"Cell Res"},{"key":"3102_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102542","volume":"7","author":"Y Huang","year":"2026","unstructured":"Huang Y, Xiao P, Qin L, Gao L, Zhao Y, Sui J, et al. Sequence-dependent splicing dysregulation drives therapy resistance in pediatric AML. Cell Rep Med. 2026;7:102542.","journal-title":"Cell Rep Med"},{"key":"3102_CR37","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm1443","volume":"12","author":"M Yan","year":"2006","unstructured":"Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med. 2006;12:945\u20139.","journal-title":"Nat Med"},{"key":"3102_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.stem.2018.05.021","volume":"23","author":"S Pei","year":"2018","unstructured":"Pei S, Minhajuddin M, Adane B, Khan N, Stevens BM, Mack SC, et al. AMPK\/FIS1-mediated mitophagy is required for self-renewal of human AML stem cells. Cell Stem Cell. 2018;23:86\u2013100.","journal-title":"Cell Stem Cell"},{"key":"3102_CR39","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1093\/bioinformatics\/btaa223","volume":"36","author":"D Mercatelli","year":"2020","unstructured":"Mercatelli D, Lopez-Garcia G, Giorgi FM. corto: a lightweight R package for gene network inference and master regulator analysis. Bioinformatics. 2020;36:3916\u20137.","journal-title":"Bioinformatics"},{"key":"3102_CR40","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/leu.2012.49","volume":"26","author":"A Ptasinska","year":"2012","unstructured":"Ptasinska A, Assi SA, Mannari D, James SR, Williamson D, Dunne J, et al. Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia. 2012;26:1829\u201341.","journal-title":"Leukemia"},{"key":"3102_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ng0398-231","volume":"18","author":"NG Larsson","year":"1998","unstructured":"Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet. 1998;18:231\u20136.","journal-title":"Nat Genet"},{"key":"3102_CR42","doi-asserted-by":"publisher","first-page":"16510","DOI":"10.1073\/pnas.1119738109","volume":"109","author":"Y Shi","year":"2012","unstructured":"Shi Y, Dierckx A, Wanrooij PH, Wanrooij S, Larsson NG, Wilhelmsson LM, et al. Mammalian transcription factor A is a core component of the mitochondrial transcription machinery. Proc Natl Acad Sci USA. 2012;109:16510\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3102_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bbrc.2011.03.114","volume":"408","author":"B Han","year":"2011","unstructured":"Han B, Izumi H, Yasuniwa Y, Akiyama M, Yamaguchi T, Fujimoto N, et al. Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth. Biochem Biophys Res Commun. 2011;408:45\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"3102_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41586-019-0993-x","volume":"567","author":"Y Shi","year":"2019","unstructured":"Shi Y, Lim SK, Liang Q, Iyer SV, Wang HY, Wang Z, et al. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma. Nature. 2019;567:341\u20136.","journal-title":"Nature"},{"key":"3102_CR45","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer Res. 2018;24:2482\u201390.","journal-title":"Clin Cancer Res"},{"key":"3102_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap TA, Daver N, Mahendra M, Zhang J, Kamiya-Matsuoka C, Meric-Bernstam F, et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023;29:115\u201326.","journal-title":"Nat Med"},{"key":"3102_CR47","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1016\/j.molcel.2024.07.019","volume":"84","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Ai Y, Abdel-Wahab O. Molecular impact of mutations in RNA splicing factors in cancer. Mol Cell. 2024;84:3667\u201380.","journal-title":"Mol Cell"},{"key":"3102_CR48","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","volume":"35","author":"J Ishizawa","year":"2019","unstructured":"Ishizawa J, Zarabi SF, Davis RE, Halgas O, Nii T, Jitkova Y, et al. Mitochondrial clpP-mediated proteolysis induces selective cancer cell lethality. Cancer Cell. 2019;35:721\u201337.","journal-title":"Cancer Cell"},{"key":"3102_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41586-025-08980-6","volume":"642","author":"M Gozdecka","year":"2025","unstructured":"Gozdecka M, Dudek M, Wen S, Gu M, Stopforth RJ, Rak J, et al. Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis. Nature. 2025;642:431\u201341.","journal-title":"Nature"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03102-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:58:28Z","timestamp":1793105908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03102-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3102"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03102-1","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}